Literature DB >> 9840917

Inhibition of Fas-induced apoptosis by Bcl-2.

A Kawahara1, T Kobayashi, S Nagata.   

Abstract

Jurkat cells express Fas, and rapidly undergo apoptosis in response to Fas ligand or an agonistic anti-Fas antibody. This apoptotic pathway is mediated by a cascade of caspases. In this report, we show that Fas activation induced the processing of caspase 8 in Jurkat cells with a time frame similar to the activation of caspase 3 and the proteolysis of nuclear proteins. Jurkat cell transformants that overexpress Bcl-2 were partially but not completely resistant to the Fas-induced apoptosis. Little processing of caspase 8 was observed upon Fas activation in these transformants. Furthermore, although caspase 8 was recruited to Fas upon Fas activation in the parental Jurkat cells, the recruitment of caspase 8 to Fas was inhibited in the transformants overexpressing Bcl-2. These results suggest that Bcl-2 inhibits Fas-induced apoptosis by preventing the formation of the death-inducing signaling complex that is composed of Fas, FADD/MORT1, and caspase 8.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840917     DOI: 10.1038/sj.onc.1202192

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.

Authors:  Yoshihiro Michishita; Makoto Hirokawa; Yong-Mei Guo; Yukiko Abe; Jiajia Liu; Kumi Ubukawa; Naohito Fujishima; Masumi Fujishima; Tomoko Yoshioka; Yoshihiro Kameoka; Hirobumi Saito; Hiroyuki Tagawa; Naoto Takahashi; Kenichi Sawada
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

2.  Expression of apoptosis-related genes in human oocytes and embryos.

Authors:  H C Liu; Z Y He; C A Mele; L L Veeck; O Davis; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2000-10       Impact factor: 3.412

3.  CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily.

Authors:  A G Eliopoulos; C Davies; P G Knox; N J Gallagher; S C Afford; D H Adams; L S Young
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.

Authors:  G Bilbao; J L Contreras; H G Zhang; M J Pike; K Overturf; G Mikheeva; V Krasnykh; D T Curiel
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.

Authors:  Bruce Frankel; Sharon L Longo; Christopher Leach; Gregory W Canute; Timothy C Ryken
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

6.  Inhibition of intracellular peroxides and apoptosis of lymphocytes in lupus-prone B/W mice by dietary n-6 and n-3 lipids with calorie restriction.

Authors:  C P Reddy Avula; Richard A Lawrence; Khaliquz Zaman; Gabriel Fernandes
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

7.  Antiapoptotic proteins Bcl-2 and Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells.

Authors:  Isabelle Matte; Denis Lane; Elodie Côté; Ann-Elise Asselin; Louis-Charles Fortier; Claude Asselin; Alain Piché
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

8.  Characterization of chronic HCV infection-induced apoptosis.

Authors:  Abdel-Rahman N Zekri; Abeer A Bahnassy; Mohamed M Hafez; Zeinab K Hassan; Mahmoud Kamel; Samah A Loutfy; Ghada M Sherif; Abdel-Rahman El-Zayadi; Sayed S Daoud
Journal:  Comp Hepatol       Date:  2011-07-23

9.  Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells.

Authors:  S Simizu; F Shibasaki; H Osada
Journal:  Jpn J Cancer Res       Date:  2000-07

10.  Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.

Authors:  J D Kelly; J Dai; P Eschwege; J S Goldberg; B P Duggan; K E Williamson; N H Bander; D M Nanus
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.